PMN
ProMIS Neurosciences Inc.
NASDAQ: PMN · HEALTHCARE · BIOTECHNOLOGY
$11.15
+2.76% today
Updated 2026-04-29
Market cap
$99.99M
P/E ratio
—
P/S ratio
4,016.22x
EPS (TTM)
$-22.61
Dividend yield
—
52W range
$6 – $40
Volume
0.0M
ProMIS Neurosciences Inc. (PMN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-522.00%
ROA
-176.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $31314.00 | $-1.69M | 100.00% | -5,382.94% | -5,388.21% |
| 2006 | $219921.00 | $-3.67M | 100.00% | -1,668.80% | -1,668.80% |
| 2007 | $464019.00 | $-6.99M | 100.00% | -1,505.39% | -1,505.39% |
| 2008 | $193631.00 | $-4.08M | 100.00% | -2,105.59% | -2,105.59% |
| 2009 | $176161.00 | $-4.76M | 100.00% | -2,704.69% | -2,704.69% |
| 2010 | $1.23M | $-3.43M | 100.00% | -278.43% | -278.43% |
| 2011 | $91090.00 | $-2.55M | 100.00% | -2,813.90% | -2,799.05% |
| 2012 | $48666.00 | $-2.19M | 100.00% | -4,510.18% | -4,505.49% |
| 2013 | $134181.00 | $-2.04M | 100.00% | -1,519.23% | -1,519.23% |
| 2015 | $14365.00 | $-1.53M | 100.00% | -10,519.48% | -10,639.79% |
| 2016 | $2002.00 | $-2.57M | 100.00% | -127,804.90% | -128,395.30% |
| 2017 | $7868.00 | $-4.79M | 100.00% | -60,772.79% | -60,844.59% |
| 2018 | $348.00 | $-7.46M | 100.00% | -2,145,008.62% | -2,145,008.62% |
| 2019 | $1202.00 | $-7.40M | -393,853.16% | -1,009,282.53% | -615,329.37% |
| 2020 | $1565.00 | $-5.66M | -203,296.10% | -361,814.19% | -361,814.19% |
| 2021 | $8138.00 | $-9.66M | -71,803.01% | -101,372.23% | -118,672.39% |
| 2022 | $8138.00 | $-18.06M | -267,648.33% | -287,293.09% | -221,949.66% |
| 2023 | $0.00 | $-17.51M | — | — | — |
| 2024 | $0.00 | $2.78M | — | — | — |
| 2025 | $0.00 | $-39.72B | — | — | — |